Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeStance Health (LFST) FCF Margin (2020 - 2025)

LifeStance Health (LFST) has disclosed FCF Margin for 6 consecutive years, with 12.21% as the latest value for Q4 2025.

  • On a quarterly basis, FCF Margin fell 500.0% to 12.21% in Q4 2025 year-over-year; TTM through Dec 2025 was 7.72%, a 87.0% increase, with the full-year FY2025 number at 7.72%, up 87.0% from a year prior.
  • FCF Margin was 12.21% for Q4 2025 at LifeStance Health, up from 4.67% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 17.21% in Q4 2024 to a low of 13.37% in Q3 2023.
  • A 5-year average of 0.97% and a median of 1.48% in 2021 define the central range for FCF Margin.
  • Peak YoY movement for FCF Margin: crashed -1129bps in 2022, then skyrocketed 1902bps in 2024.
  • LifeStance Health's FCF Margin stood at 2.13% in 2021, then soared by 622bps to 11.13% in 2022, then tumbled by -83bps to 1.92% in 2023, then surged by 797bps to 17.21% in 2024, then decreased by -29bps to 12.21% in 2025.
  • Per Business Quant, the three most recent readings for LFST's FCF Margin are 12.21% (Q4 2025), 4.67% (Q3 2025), and 16.4% (Q2 2025).